DRKS00021199已完成未知
Effect of CytoSorb adsorber on hemodynamic and immunological parameters in critical ill patients with COVID-19 - CYTOCOV-19
niversitätsklinikum Hamburg Eppendorf0 个研究点目标入组 24 人开始时间: 2020年5月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 90 Years(—)
- 性别
- All
入选标准
- •1. Confirmed COVID-19
- •2. refractory shock (mean arterial pressure = 65mmHg due to vasopressor therapy and adequate volume resuscitation; norepinephrine = 0.2µg/kg bodyweight; Interleukine-6 = 500ng/l
- •3. indication for continuous renal replacement procedure pr extracorporeal membrane oxygenation
- •4. age = 18 years and = 90 years
排除标准
- •1. Liver Cirrhosis Child-Pugh C
- •2. therapy restriction (DNR), moribund patient
- •3. expected survival due to concomitant diseases = 14 days
- •4. pregnancy or lactation
- •5. participation in another interventional study
研究者
相似试验
招募中
不适用
Effect of CytoSorb adsorber on hemodynamic and immunological parameters in refractory septic shockA41Other sepsisDRKS00015483niversitätsklinikum Hamburg Eppendorf32
已完成
不适用
Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19COVID-19NCT04344080Universitätsklinikum Hamburg-Eppendorf24
招募中
不适用
Adjuvant Therapy With CytoSorb in Refractory Septic ShockSeptic ShockNCT04013269Universitätsklinikum Hamburg-Eppendorf32
招募中
不适用
Study into the effect of CytoSorb (cytokine adsorber) in relation to the MICrocirculation of patients with Septic Shock and Acute Kidney Injury at the ICU; MICSS-AKINL-OMON53033Erasmus Universiteit Rotterdam40
已完成
不适用
Impact of Hemoadsorption (CytoSorb® Filter) on Plasma Levels of Anti-infective AgentsDRKS00034788Charité-Universitätsmedizin Berlin23
